David L. Lacey

机构：Amgen (United States)

发表论文 123 篇 · 总被引 43479 次 · h-index 64

代表论文

• Osteoclast differentiation and activation (2003 · Nature · 被引 6722)
• Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival (2010 · Cell · 被引 949)
• Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength (2008 · Journal of Bone and Mineral Research · 被引 948)
• Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis (2008 · Journal of Bone and Mineral Research · 被引 791)
• Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab (2012 · Nature Reviews Drug Discovery · 被引 699)
• Role of RANK ligand in mediating increased bone resorption in early postmenopausal women (2003 · Journal of Clinical Investigation · 被引 699)